March 29, 2020

Percutaneous Coronary Intervention (PCI) Devices Market Is Expected To Reach Worth US$ 8.70 Bn by 2026

According to the latest report published by Credence Research, Inc. “Percutaneous Coronary Intervention Devices Market – Growth, Future Prospects and Competitive Analysis, 2018-2026,” the global market for percutaneous coronary intervention devices was valued at US$ 5.98 billion in 2017 and is expected to reach US$ 8.70 billion by 2026, increasing to CAGR by 4.3 per cent from 2018 to 2026.

Market Insights 

The global market for percutaneous coronary intervention devices is valued at US$ 5.98 billion for 2017 and is mainly driven by an increase in the global burden of heart disease, diabetes and coronary artery disease. Percutaneous coronary intervention is a non-surgical technique used to prevent the narrowing of coronary arteries by removing plaque using PTCA balloon catheters and placement of coronary stents. According to the American Heart Association, an estimated 15.5 million people over 20 years of age had coronary artery disease in 2015 and this number is expected to increase further in the future. Other important factors contributing to the increase in the number of percutaneous coronary intervention procedures include a reduced risk of complications and infections compared to conventional treatment methods. However, the lack of qualified professionals to perform the procedures hinders the growth of the global market for percutaneous coronary intervention devices.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/percutaneous-coronary-intervention-pci-devices-market

Based on device types, the market for global percutaneous coronary intervention devices is segmented into coronary stents, PTCA catheters, and coronary guide wires. These devices are used to treat coronary artery disease during PCI procedures. The Coronary stents segment is expected to grow at a significant pace in the forecast period due to the introduction of new products on the market.

Based on end-users, the global market for percutaneous coronary intervention devices is divided into hospitals, ambulatory surgical centers (ASCs) and catheterization laboratories. In terms of market value, the hospital segment is expected to dominate the global market for percutaneous coronary intervention devices by 2017 due to increased availability of qualified professionals required to perform the procedure and increased footprint of target patients in hospitals. However, as the healthcare infrastructure is expanding in both developed and developing economies, and there is a greater preference for specialized treatment sites in both patients and caregivers, the dominance of hospitals is expected to be challenged by catheterization laboratories.

Based on the geographic segmentation, North America is expected to dominate the global market for percutaneous coronary intervention devices by 2017, due to a greater public awareness of heart disease management and a better reimbursement scenario. However, the spread of medical tourism and the thriving health market in Asia-Pacific will make the region grow faster than the global benchmark. Market players have a diverse product portfolio, from offering stents to the entire PCI portfolio.

Major players in the global percutaneous coronary intervention devices market include Abbott Laboratories, Inc., B. Braun Melsungen AG, Biosensors International Group, Biotronik SE & Co. KG, Boston Scientific Corporation, Getinge AB, Johnson & Johnson, Medtronic plc, St. Jude Medical LLC, and Terumo Corporation.

Access Free Sample Copy of Research Report: https://www.credenceresearch.com/sample-request/58198

[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

Report Scope by Segments

By Device Type

  • Coronary Stents
  • PTCA Catheters
  • Coronary Guidewires

By End User Type

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Catheterization Labs

By Geography Segment

  • North America (the U.S., Rest of North America)
  • Europe (U.K., Germany, France, Rest of Europe)
  • Asia Pacific (China, Japan, India, Rest of Asia Pacific)
  • Rest of World (Middle East & Africa (MEA), Latin America)

Access Free Sample Copy of Research Report: https://www.credenceresearch.com/sample-request/58198

Leave a Reply

Your email address will not be published. Required fields are marked *